Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with platinum-based doublet chemotherapy (PT-DC) in advanced non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Antonia, S. J.; Brahmer, J. R.; Gettinger, S. N.; Chow, L. Q. M.; Juergens, R. A.; Shepherd, F. A.; Laurie, S. A.; Gerber, D. E.; Goldman, J. W.; Shen, Y.; Harbison, C.; Alaparthy, S.; Chen, A. C.; Borghaei, H.; Rizvi, N. A.
Abstract Title: Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with platinum-based doublet chemotherapy (PT-DC) in advanced non-small cell lung cancer (NSCLC)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613204175
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.8113
Notes: Meeting Abstract: 8113 -- 50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, IL -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Naiyer A Rizvi
    166 Rizvi